More information about the coronavirus and restrictions related to it is available calling 1247 (from abroad +372 600 1247).

Vaccines

Expand all questions

If there are more than 2 weeks between the first vaccine shot and the infection, the second shot will not be administered. If there are less than 2 weeks, the second shot will be administered after about 6 months have passed.

Last updated: 20.05.2021 16:53

Did this response answer your question?

The period between the COVID-19 vaccine and the tick-borne encephalitis vaccine shots should be 14 days.

Last updated: 20.05.2021 16:52

Did this response answer your question?

The manufacturer has determined the intervals between administering the vaccine doses according to the results of clinical studies. The period prescribed by the manufacturer provides the highest efficacy of the vaccine, based on the results of the studies. For this reason it is important to administer the second dose at the prescribed time, generally no sooner than the summary of the vaccine properties suggests. For instance, if a person becomes ill and cannot go the get the second dose at the agreed upon time, the second dose can be administered later but preferably at first opportunity after recovery.

The interval between the two shots by vaccine:

  • the Pfizer/BioNTech vaccine: 6 weeks (maximum protection is achieved 7 days after receiving the second dose)
  • the Moderna vaccine: 4 weeks (maximum protection is achieved 14 days after receiving the second dose)
  • the AstraZeneca vaccine: 12 weeks (maximum protection is achieved 15 days after receiving the second dose)

Last updated: 31.05.2021 09:53

Did this response answer your question?

If you are feeling good, you may work out. If you get side effects like fever, we recommend refraining from working out.

Last updated: 20.05.2021 16:26

Did this response answer your question?

Having had COVID-19 is not a contraindication to vaccination. According to the current recommendation, the people who have recovered are also being vaccinated with one dose of the COVID-19 vaccine.

The level of antibodies provided by vaccination is tens of times higher than we get just by having the virus. This will also give us longer immunity.

While the vaccine volumes are limited, the preferred target group should be those who have not had COVID-19 within the last 6 months.

If a person has had the virus without being aware of it himself, he will be vaccinated with two doses of the vaccine, which is not dangerous to the organism.

Last updated: 20.05.2021 16:25

Did this response answer your question?

We do not recommend consuming alcohol neither before nor after vaccination. Temporary mild side effects, like fever, headache etc., may occur after receiving the COVID-19 vaccination. In interaction with the vaccine, the alcohol could make you feel even worse.

Last updated: 20.05.2021 16:25

Did this response answer your question?

Alcohol consumption is not a direct contraindication and does not affect the emergence of antibodies. Chronic alcoholics might have a weaker immune response.

It is definitely not allowed to go to get vaccinated while drunk! We ask you to show respect towards doctors and nurses that are administering the vaccinations.

It is not recommended to use alcohol to mitigate the possible side effects of vaccination.

Last updated: 20.05.2021 16:25

Did this response answer your question?

It is allowed to eat before vaccination. If you wish, you can also go without eating first. We would rather recommend eating something first so that missing a meal would not make you feel worse overall.

Last updated: 20.05.2021 16:25

Did this response answer your question?

The state immunoprophylaxis expert committee recommends vaccinating people who have recovered from COVID-19 with one dose on the 6th month after recovery and consider the course of vaccinations completed with this.

The committee recommends vaccinating with one dose even if more than six months have passed since recovery from COVID-19, in order to ensure long term protection.

It is not necessary to administer the second dose to people who have recovered, and this might also cause more side effects.

If a person gets COVID-19 within two weeks of receiving the first dose, he considered recovered from COVID-19, vaccinated with one dose on the 6th month after recovery, and his course of vaccinations should be considered completed with this.

A person who has been vaccinated with one dose and gets COVID-19 more than two weeks after receiving the first dose but before receiving the second dose, does not need to be administered the second dose and the course of vaccinations may be considered completed.

Last updated: 20.05.2021 16:24

Did this response answer your question?

With these vaccines, the genetic material of the pathogen is delivered into the organism in the form of either DNA or RNA, and based on the information contained in it, the organism itself will synthesize the part of the pathogen necessary for the creation of immunity, i.e. the antigen. As a rule, this is some protein of the pathogen, in the case of the coronavirus the spike protein on its surface. One way of describing the situation would be that if an organism needs food daily, in the case of one vaccine a ready meal is delivered, in the case of another the organism is delivered a recipe and the organism itself is capable of preparing the food with the help of the recipe.

Compared to a protein, the mRNA is a simpler molecule and thus the production of mRNA is generally faster than the production of vaccines that have been in use up until now. The idea of vaccines based on mRNA is actually already decades old and this type of vaccines have been tested in clinical studies for different infectious diseases. For different reasons, none of them have been taken into use on humans thus far. There is reason to hope that technological development will allow it now.

More information is available here: https://somblogi.wordpress.com/2020/12/22/triin-suvi-ja-pille-saalik-ravimiametist-selgitavad-kuidas-toimivad-meie-kehas-koroonavaktsiini-erinvad-tuubid/

Last updated: 27.12.2020 17:16

Did this response answer your question?

As several different vaccines are being developed and coming to the market, their characteristics are certain to somewhat differ from each other.

Whether a vaccine is suitable or unsuitable for somebody is noted on the information sheet of the vaccine.

Who should be vaccinated and how is best known to the medical worker who carries out the vaccination.

More about the vaccines can be read from here: https://vaktsineeri.ee/en/covid-19/covid-19-vaccines/

Last updated: 26.04.2021 09:31

Did this response answer your question?

The objective of the vaccines is to imitate the virus. We have to fool the organism with the vaccine, give it the impression that it is being attacked by SARS-CoV-2. With the help of the vaccine, the immune system learns to recognize the spike proteins of the virus and fight against the virus more effectively.

No medicine or vaccine is 100% safe. What we can say with full certainty, however, is that the danger of getting severe side effects from the vaccine is hundreds, if not thousands, of times smaller than contracting the coronavirus and suffering through it severely.

The side effects of the vaccines are temporary and no long-term side effects have been established up until now. COVID-19, however, causes long-term damage often. Thus using new vaccines is a calculated risk that clearly favours the vaccines.

Read more from here: https://www.ut.ee/et/teadus/teadlaste-vastused-koroonakusimustele (in Estonian)

Last updated: 08.04.2021 14:54

Did this response answer your question?

One of the most important goals of the COVID-19 vaccines is to avoid severe (requiring hospitalisation) and mortal forms of the disease. All vaccines in use fulfil this goal very effectively, all vaccines offer a practically hundred percent protection from severe forms of the disease.

Vaccination also manages to avoid most of the mild and moderate cases of the COVID-19 disease: the Pfizer vaccine does it at the rate of 95% and the Moderna vaccine at the rate of 94%.

The effectiveness of the AstraZeneca vaccine in avoiding symptomatic disease is 60% (even though it is possible to increase the effectiveness to over 80% by using different dosing schemes).

Last updated: 26.04.2021 09:31

Did this response answer your question?

Vaccination will be postponed if the patient is severely ill with COVID-19.

Having had COVID-19 or seropositivity (i.e if there already is a determinable amount of antibodies in the blood) is not a contraindication to vaccination:

People who have had COVID-19 should be vaccinated with only one dose of the vaccine, preferably in the sixth month after recovery. After that the course of vaccination should be considered completed. Even if more than 6 months have passed since recovery, only one dose of the vaccine should be administered in order to ensure long-term protection. People who have recovered do not need to be administered a second dose, also because the reactogenicity of the vaccine might be higher in that case and there might be more side effects.

People who get COVID-19 after receiving the first dose of the vaccine will not be administered the second dose and are considered vaccinated for the following six months.

Last updated: 13.05.2021 09:13

Did this response answer your question?

Herd immunity is usually calculated based on the infection multiplier R (how many people will one sick person infect). If R is low, the percentage of vaccinated persons can be low as well. In the case of the coronavirus, the necessary critical mass is estimated to be about 70% of the society. If more severe strains that infect faster (the British strain) or can infect vaccinated people as well (the Brazilian strain) occur, the critical mass of vaccinated people should also be larger. For instance, the R-rate for measles is about 15, thus herd immunity for measles requires 95% of people to be vaccinated.

As children will not be getting vaccinated in the near future, the main onus for reaching herd immunity will fall on responsible adults.

Read more: https://www.ut.ee/et/teadus/teadlaste-vastused-koroonakusimustele (in Estonian).

Last updated: 26.04.2021 09:38

Did this response answer your question?

Viruses mutating is a regular process. All mutations do not lead to reduced efficacy of the developed vaccines but the genetic changes in virus strains are still followed closely in order to evaluate their effect on the vaccines that have been or are being developed.

Last updated: 27.12.2020 17:08

Did this response answer your question?

Most of the vaccines we have received thus far require two doses. Even though a certain immune protection occurs even after the first dose, it is not strong enough, which is why it is important to get both shots if the vaccine requires a two-dose course.

The Janssen COVID-19 vaccine course requires only one shot.

Last updated: 30.04.2021 11:46

Did this response answer your question?

The joint European Union vaccine portfolio contains the vaccines and vaccine candidates of 8 vaccine manufacturers. The European Commission has signed advance purchase agreements with the following vaccine manufacturers – AstraZeneca, Sanofi, Janssen Pharmaceutica NV, Pfizer/BioNTech, Curevac and Moderna.

Estonia has currently joined the advance purchase agreements with 5 vaccine manufacturers -- AstraZeneca, Janssen Pharmaceutica NV, Pfizer/BioNTech, Curevac and Moderna. Estonia has the possibility of joining the Sanofi advance purchase agreements later.

Additionally, the negotiations are ongoing between the European Commission and the vaccine manufacturer Novavax. At the request of several member states, the negotiations have also been started with the vaccine manufacturer Valneva.

Last updated: 26.04.2021 09:40

Did this response answer your question?

Those vaccines that are being processed and reviewed by the European Medicines Agency for receiving a marketing authorisation do not contain mercury particles or other unknown compounds. Finding microchips or other such things in vaccines belongs to the sphere of conspiracy theories. All medicines that receive a marketing authorisation in the European Union are checked, safe, of high quality and effective. All ingredients of the vaccine are listed on the information sheet of the vaccine.

More information on the vaccines can be found from here: https://vaktsineeri.ee/en/covid-19/covid-19-vaccines/

Last updated: 26.04.2021 09:31

Did this response answer your question?

Vaccinating against the COVID-19 disease is probably the only sustainable solution in order to prevent the spread of the COVID-19 disease and return to the regular order of life. The contribution of each person is important for stopping the COVID-19 pandemic.

All the vaccines available in Estonia are very effective in preventing the severe form of the disease. Even if some of the vaccinated people do get sick, they go through the disease without ending up in a hospital.

The first results of vaccinating against the COVID-19 disease are apparent in Estonia as well -- the COVID-19 infection rate has gone down among health care workers. Experience from other countries confirms this -- severe progression of the disease and hospitalisations have gone down more than 80% in both the United Kingdom and Israel.

Vaccination is many times safer than suffering through the COVID-19 disease. The progression of the COVID-19 disease is unpredictable and differs from patient to patient -- because of comorbidities or high age, the disease can progress very severely. The possible longterm effects of suffering through the COVID-19 disease are currently also not known.

According to the data available by now and based on our previous knowledge, we can presume that the COVID-19 vaccines also protect relatively well from the transmission of the virus -- exactly how well and effectively will become clear over time as the studies are ongoing.

By getting vaccinated we are also protecting those who cannot protect themselves. There are people among us who cannot get vaccinated because of their health conditions.

Last updated: 13.05.2021 09:13

Did this response answer your question?

More information about the coronavirus and restrictions related to it is available calling 1247 (from abroad +372 600 1247).